February/March #132 : How the Other Half Lives - by Christopher Murray

POZ - Health, Life and HIV
Subscribe to:
POZ magazine
Newsletters
Join POZ: Facebook MySpace Twitter Pinterest
Tumblr Google+ Flickr MySpace
POZ Personals
Sign In / Join
Username:
Password:

Back to home » Archives » POZ Magazine issues




Table of Contents
 

The View

Status Seekers

Mentors-Feb/March 2007




Filling Station

Behind Every Good Woman?

How the Other Half Lives

Juiced

Reyataz: Out With the Two Old, and In With One New

Ask the Sexpert-Feb/March 2007

Clap Trap

In the House

Pay It Forward

Health By Chocolate

Heart Condition




Saved by the Belly

Party Games

Discomfort Inn

Disobedience School

Styx and Stones

Parental Guidance

Oral Majority

Office Flirt

Who’s the Boss




Ed Letter-Feb/March 2007

Mailbox-Feb/March 2007

Catch of the Month-Feb/March 2007



 
Most Popular Lessons

The HIV Life Cycle

Shingles

Herpes Simplex Virus

Syphilis & Neurosyphilis

Treatments for Opportunistic Infections (OIs)

What is AIDS & HIV?

Hepatitis & HIV



email print

February / March 2007


How the Other Half Lives

by Christopher Murray

Will gender-changing hormones neuter your HIV regimen?

Gender-switching hormones may morph your voice, body hair and fat. If you’re positive, will HIV meds interact with hormone treatments, threatening unwanted alterations as well?

“There are no data,” says Gal Meyer, MD, of New York City’s Callen-Lorde Community Health Center, which has many positive transgender clients. We do know this: Hormone treatments, before or after transgender surgery, can cause blood clots and other side effects, some resembling those of HIV meds. Some HIV meds (think protease inhibitors) can alter hormone levels in the blood. Most information, however, remains anecdotal or was projected from studies of oral contraceptives containing estrogen, the male-to-female hormone.

On the flip side, Meyer says, “I’ve never seen [interactions where hormones alter HIV drug levels].” He has, however, seen one case where an HIV med, non-nuke Viramune, seemed to undercut estrogen. Yet a 2005 study listed many potential interactions, and a 2006 American Journal of Public Health report found disproportionately high numbers of trans folk ducking HIV med doses. Kim Watson, a positive transgender advocate from the Bronx, adds that trans people often skip needed hormone-level checks because “as long as the hormones help them look the way they want, they don’t worry about contraindications with HIV drugs.”  

Ray Carannante, a social worker at NYC’s Gender Identity Project, says that’s because positive trans people often focus instead on getting gender-changing surgeries. “I have a client who has been trans—and positive—for many, many years,” he says. “She still can’t find a surgeon to help her.” Remember: While seeing a doc, keep your hormones—and HIV—in check.     


[Go to top]

Facebook Twitter Google+ MySpace YouTube Tumblr Flickr Instagram
Quick Links
Current Issue

HIV Testing
Safer Sex
Find a Date
Newly Diagnosed
HIV 101
Disclosing Your Status
Starting Treatment
Help Paying for Meds
Search for the Cure
POZ Stories
POZ Opinion
POZ Exclusives
Read the Blogs
Visit the Forums
Job Listings
Events Calendar
POZ on Twitter

Ask POZ Pharmacist

Talk to Us
Poll
Are you buying holiday gifts that raise HIV/AIDS awareness?
Yes
No

Survey
Smoke Signals

more surveys
Contact Us
We welcome your comments!
[ about Smart + Strong | about POZ | POZ advisory board | partner links | advertising policy | advertise/contact us | site map]
© 2014 Smart + Strong. All Rights Reserved. Terms of use and Your privacy.
Smart + Strong® is a registered trademark of CDM Publishing, LLC.